1.	Phase III Randomized Adjuvant Preoperative Total Parenteral Nutrition in Patients Undergoing Surgery for Carcinoma of the Esophagus, Stomach, Pancreas, Colon, and Rectum Phase: Phase III Type: Supportive care Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: NCI-83-C-103, NCI-T83-1089N, T83-1089
2.	Randomized Study of the Treatment of Malnutrition in Patients With Ewing's Sarcoma Undergoing Intensive Chemoradiotherapy (Summary Last Modified 11/2001) Phase: No phase specified Type: Supportive care Status: Completed Age: Not specified Sponsor: NCI Protocol IDs: NCI-84-C-229, NCI-T84-0540, T84-0540
3.	Phase II Randomized Pilot Study of Pentoxifylline vs Placebo for Anorexia and Cachexia in Patients with Metastatic Malignancies (Summary Last Modified 03/98) Phase: Phase II Type: Supportive care Status: Closed Age: adult Sponsor: NCI Protocol IDs: SWOG-9327, NCI-P94-0058
4.	Phase III Randomized Study Comparing Urokinase With Heparin in Preventing Infection and Occlusion in Central Venous Catheters in Children With Cancer Phase: Phase III Type: Supportive care Status: Completed Age: 3 months-21 years Sponsor: NCI Protocol IDs: CCG-S921
5.	Study of Mechanisms to Prevent Nosocomial Transmission of Varicella Zoster Virus and Techniques to Study the Epidemiology and Routes of Transmission of Varicella Zoster in Immunocompromised Patients (Summary Last Modified 11/87) Phase: No phase specified Type: Supportive care Status: Closed Age: 2 and over Sponsor: NCI Protocol IDs: NIH-82-CC-28, NCI-T84-0406N, T84-0406
6.	Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy Phase: No phase specified Type: Supportive care Status: Closed Age: 21 and under Sponsor: NCI, Other Protocol IDs: MC0896, NCI-2010-01938, 09-007533, NCT01200602
7.	Randomized Study of Megestrol as an Appetite Stimulant in Children With Cancer-Related Cachexia (Summary Last Modified 02/2002) Phase: No phase specified Type: Supportive care Status: Completed Age: Under 21 Sponsor: NCI Protocol IDs: MCC-0004, NCI-3990, NCI-P02-0202
8.	Randomized Study of Psychosocial Interventions in Women With Recurrent or Stage I, II, or IV Breast Cancer. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: No phase specified Type: Supportive care Status: Completed Age: 25 and over Sponsor: NCI Protocol IDs: PMBC-HS05-182, MWH-99-062, CMU-00000603, FWA00004206, NCT00416780
9.	Phase I Study of NG-Monomethyl-L-Arginine for IL-2-Induced Hypotension in Patients with Metastatic Melanoma (Summary Last Modified 12/98) Phase: Phase I Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-95-C-0136
10.	Placebo-Controlled Evaluation of Megestrol Acetate in the Treatment of Cancer-Related Anorexia and Cachexia Phase: No phase specified Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-889251, MAYO-889251
11.	Dose-Response Evaluation of Megestrol to Treat Anorexia and Cachexia in Patients with Cancer Phase: No phase specified Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-899255, MAYO-899255, NCI-P90-0009
12.	Dose-Response Evaluation of Megestrol to Treat Cachexia in Patients with Advanced Lung or Colorectal Cancer (Summary Last Modified 12/92) Phase: No phase specified Type: Supportive care Status: Closed Age: over 16 Sponsor: NCI Protocol IDs: CLB-8971, NCI-P90-0012
13.	Phase III Randomized Study of Megestrol Acetate vs Fluoxymesterone vs Dexamethasone for the Treatment of Cancer-Related and Cancer Treatment-Related Anorexia and Cachexia Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-919252, MAYO-919252, NCI-P92-0004
14.	Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy Phase: Phase II Type: Supportive care Status: Completed Age: 1 to 21 Sponsor: NCI, Other Protocol IDs: J0326, CDR0000441133, P30CA006973, JHOC-J0326, JHOC-03070804, J0326, NCT00258180
15.	Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant Phase: No phase specified Type: Supportive care Status: Completed Age: 11 and over Sponsor: NCI, Other Protocol IDs: IR 7141, P30CA077598, UMN-2003NT063, CDR0000642276, IR-6980, FHCRC-2357.00, 2003NT063, NCT00920842
16.	A Standardized Nursing Intervention Protocol for HCT Patients Phase: No phase specified Type: Health services research, Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 05081, R01CA107446, P30CA033572, CHNMC-05081, CDR0000643265, NCT00951626
17.	Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment Phase: Phase II Type: Supportive care Status: Completed Age: 2 to 20 Sponsor: NCI, Other Protocol IDs: CDR0000309056, MCC-0205, NCT00066248
18.	Phase III Double Blind, Placebo Controlled, Randomized Study of the Effectiveness of Pentoxifylline in Maintaining Weight in Patients Undergoing Chemotherapy for Metastatic Cancer (Summary Last Modified 07/98) Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: URCC-U2994, URCC-2994PM, NCI-P97-0087
19.	Phase I Study of NG-monomethyl-L-arginine for Interleukin-2 Induced Hypotension in Patients With Metastatic Melanoma or Metastatic Renal Carcinoma Phase: Phase I Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-99-C-0018, NCI-T95-0032, T95-0032
20.	Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000069218, NCCTG-989255, CAN-NCIC-SC18, NCI-P02-0205, SC18, NCT00031707
21.	Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000257027, NCCTG-N00C1, NCI-P02-0232, MC00C8, 1497-00, N00C1, NCT00046904
22.	Creatine in Treating Patients With Cancer-Associated Weight Loss Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000360798, NCCTG-N02C4, N02C4, NCT00081250
23.	Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer Phase: No phase specified Type: Educational/Counseling/Training, Supportive care Status: Completed Age: Not specified Sponsor: NCI, Other Protocol IDs: CDR0000634536, R01CA122704, ECU-08-0485, 08-0485, PROCARE, NCT00869739
24.	Low Antioxidant Diet in Controlling Cachexia in Patients With Oropharyngeal Cancer Receiving Chemotherapy and Radiation Therapy Phase: Phase I Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Completed Age: Over 18 Sponsor: NCI, Other Protocol IDs: LCCC 0523, CDR0000549772, UNC-LCCC-0523, NCT00486304
25.	Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients Phase: No phase specified Type: Educational/Counseling/Training, Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000452966, R01CA101704, P30CA023108, DMS-0226, DMS-CPHS-16004, NCT00253383